Table 2

Raw data and percentage differences for males and females in both groups

GroupCSAPeak torque
Raw data (cm2)Mean of % differences (95% CI)Paired t testRaw data (Nm)Mean of % differences (95% CI)Paired t test
*Statistically significant within groups.
CSA, cross-sectional area; D, dominant; I, injured; ND, non-dominant; Nm, Newton metres; PFPS, patellofemoral pain syndrome; UI, un-injured; 95% CI, 95% confidence intervals.
Control (females, n = 6)17.85±5.7 ND1.69% (−0.6 to 3.9)0.10295.2±14.9 ND7.4% (0.8 to 13.9)0.038*
18.07±5.5 D102.1±16.5 D
Controls (males, n = 4)22.91±2.4 ND0.73% (−0.1 to 1.6)0.079154.3±16.7 ND7.9% (−2.9 to 18.9)0.09
23.07±2.3 D165.8±8.3 D
Control (total n = 10)19.87±5.2 ND1.31% (0.07 to 2.5)0.020*118.8±33.9 ND7.6% (3.2 to 12)0.005*
20.08±5.1 D127.6±35.4 D
PFPS (females, n = 35)16.82±4.6 I4.57% (1.5 to 7.6)0.0001*82.6±27.8 I22% (13.4 to 32)0.0001*
17.39±4.5 UI95.9±27.1 UI
PFPS (males, n = 22)20.03±3.8 I2.38% (0.8 to 3.9)0.001*118.7±36.5 I15% (8.1 to 22.7)0.001*
20.31±3.9 UI135.5±38.8 UI
PFPS (total n = 57)18.06±4.6 I3.38% (1.3 to 5.4)0.0001*96.5±35.8 I18.4% (13 to 23.8)*0.0001*
18.32±4.4 UI111.2±37.3 UI
Trauma (total n = 5)20.02±5.3 I7.66% (0.4 to 14.9)124.8±66.6 I36.6% (−33.5 to 106.7)
21.76±6.9 UI150.2±55.9 UI